Continued Respiratory Therapy Phone: 866-382-0799


Idiopathic Pulmonary Fibrosis: A Deadly Progressive Fibrotic Lung Disease

Course: #1484Level: Advanced 1 Hour 407 Reviews
Video

Idiopathic pulmonary fibrosis is a progressive fibrotic lung disease affecting individuals worldwide. This advanced course provides familiarity with current literature findings in epidemiology, pathology, and diagnosis of IPF. In addition, this course reviews future therapeutic directions and clinical applications for best practice and management.

Preview Exam
unlimited ceu access $99/year Join Now

On Demand

Course Type: Video

CEUs/Hours Offered: AARC - CRCE/1.0; CE Broker/1.0 Direct Delivery Of Respiratory Care Services, CE Broker #20-908584; IACET/0.1

Course Preview

Watch the first six minutes of the course. Register for immediate access to the full course, which will also appear on your Pending Courses page.

Learning Outcomes

  • checkmarkAfter this course, participants will be able to describe the epidemiology and pathogenesis of idiopathic pulmonary fibrosis (IPF).
  • checkmarkAfter this course, participants will be able to explain the diagnostic algorithm for IPF and the importance of a multidisciplinary team meeting.
  • checkmarkAfter this course, participants will be able to recognize awareness of the optimal multifaceted approach to the treatment of IPF.

Course created on April 19, 2022

Agenda

0-5 Minutes Introduction
5-15 Minutes What is IPF: Epidemiology and Pathogenesis
15-25 Minutes Diagnosis of IPF: Clinical, Physiologic, Radiologic, and Pathologic Characteristics
25-40 Minutes Optimal Treatment for IPF
40-50 Minutes Importance of the Multidisciplinary Team Meeting
50-55 Minutes Future Diagnostics and Therapeutics
55-60 Minutes Summary, Q&A

Reviews

407 Reviews

Presented By


More
Presenter Disclosure: Presenter Disclosure: Financial: Dr. Anoop M. Nambiar is a Professor of Medicine and Founding Director of the Center for Interstitial Lung Disease at the University of Texas Health Science Center at San Antonio. Dr. Nambiar has received research grants from Pulmonary Fibrosis Foundation, Nitto Denko, Genentech/Roche, FibroGen, Pepper Center OAIC, Galapagos, and personal fees from Boehringer-Ingelheim, Roche/Genentech and Varacyte. He also received an honorarium for presenting this course. Non-financial: Dr. Nambiar is an active member of the American Thoracic Society, American College of Chest Physicians, and European Respiratory Society.

Sponsor Disclosure: This Course is presented by Continued Respiratory Therapy.

Content Disclosure: This learning event does not focus exclusively on any specific product or service.

Course participation information

To ensure you are ready to participate, please complete our short Test Drive to prepare your computer to view the course.

View Course Help

NOTE: Full attendance for all courses is mandatory. Please view the entire course.

Passing an online exam and completing a course evaluation will be required to earn continuing education credit.

Live Webinars allow presenter and participant interaction. The exam and course evaluation for these courses must be completed within 7 days of the event.

On-demand courses include texts, video and audio recordings of live webinars, and multimedia formats. The exam and course evaluation for on-demand courses must be completed within 30 days of course registration.

To participate in the course, complete the exam and course evaluation, and earn continuing education credit, you must be a Continued Respiratory Therapy member. Participants must complete the entire course; partial credit is not allowed.

Continued Respiratory Therapy is committed to ensuring accessibility to the widest possible audience. We are continually improving the user experience for everyone. If you have questions, requests, or would like to report an accessibility-related issue, please email accessibility@continued.com. We will review your request and respond in a timely manner.

Visit our Contact us page or give us a call if you have questions.

American Association for Respiratory Care

American Association for Respiratory Care

This non-traditional program has been approved for a maximum of 1 contact hour(s) Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care, 9425 N. MacArthur Blvd. Suite 100 Irving TX 75063. Course # 187228000


CE Broker

CE Broker

Continued Respiratory Therapy is an approved provider for CE Broker, provider #50-30700. This course is offered for 1.0 hours. If you are a licensed respiratory therapist in Alabama, Florida, Georgia, Kansas, Louisiana, Mississippi, New Hampshire, Oklahoma, South Carolina or Texas, CE Broker may be of interest to you. For Florida respiratory therapists, this course is registered in the Direct Delivery of Respiratory Care Services category.


International Association for Continuing Education and Training

International Association for Continuing Education and Training

Continued, LLC, is accredited by the International Association for Continuing Education and Training (IACET). Continued complies with the ANSI/IACET Standard, which is recognized internationally as a standard of excellence in instructional practices. As a result of this accreditation, Continued is authorized to issue the IACET CEU. Continued, LLC, is authorized by IACET to offer 0.1 CEUs for this program.



We recognize that state CE requirements are constantly changing. If you have any questions regarding our courses and your state requirements, please contact us at 866-382-0799 or contact Customer Service.

Our site uses cookies to improve your experience. By using our site, you agree to our Privacy Policy.